The novel chimeric multi-agonist peptide (GEP44) reduces energy intake and body weight in male and female diet-induced obese mice in a glucagon-like peptide-1 receptor-dependent manner is a research paper published in Frontiers in Endocrinology (2024). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Veterans Affairs
Grant: 5I01BX004102
U.S. Department of Defense
Grant: 6W81XWH201029901
National Institutes of Health
Grant: P30DK017047, R01DK115976, R01DK135125
BLRD VA
Grant: I01 BX004102
NIDDK NIH HHS
Grant: R01 DK135125
NIDDK NIH HHS
Grant: R01 DK115976
NIDDK NIH HHS
Grant: U2C DK135074
NIDDK NIH HHS
Grant: P30 DK017047
NIA NIH HHS
Grant: R01 AG085572
National Institutes of Health
Grant: 1R01DK135125-01A1
Development of Anorexigenic and Glucoregulatory Chimeric Peptides
National Institutes of Health
Grant: 5R01DK115976-02
Role of Brown Adipose Tissue Thermogenesis in Oxytocin-Elicited Weight Loss
National Institutes of Health
Grant: 2P30DK017047-42
Diabetes Research Center
National Institutes of Health
Grant: 5I01BX004102-04
Role of Brown Adipose Tissue Thermogenesis in Oxytocin-Elicited Weight Loss in Rodents and Nonhuman Primates
FWCI
1.61
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals